Counter-Strike: NIP vs Sangal (BO3) - Stake Ranked Episode 4: Closed Qualifier PlayoffsMap Handicap: NIP (-1.5) vs Sangal (+1.5)
Open$117as of
Odds now
The market prices a 47% chance that this market resolves Sangal, as of .
Sangal47¢
NIP53¢
as of
What would make this resolve Sangal?
This market refers to the Counter-Strike Round of 16 match between NIP and Sangal in the Stake Ranked Episode 4: Closed Qualifier Playoffs, initially scheduled for September 3, 2026 at 10:30 AM ET.
This market will resolve to "NIP" if NIP wins 2 or more maps than Sangal in this match.
Otherwise, this market will resolve to "Sangal".
Maps won by forfeit, disqualification, walkover, or default are counted towards the handicap, provided that the match is completed.
If the match is canceled (not played at all for any reason) or ends in a tie, this market will resolve to 50-50.
If the match is postponed, it must be rescheduled to a start time on or before September 17, 2026 at 11:59 PM ET (14 calendar days after the originally scheduled start of September 3, 2026 at 10:30 AM ET). If, by that deadline, the most recently announced rescheduled start time is on or before the deadline, this market resolves based on the result of the match as played. Otherwise, this market resolves 50-50, regardless of whether the match is subsequently played.
If the match begins but is not completed, and one team wins due to the opponent's match forfeiture, disqualification, or walkover, this market will resolve to 50-50.
If the match ends due to the clinching map being forfeited this will count as a completed match.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
Related markets
See all outcomes for Counter-Strike: NIP vs Sangal (BO3) - Stake Ranked Episode 4: Closed Qualifier Playoffs — the full event, with combined odds and signal timeline.